ទំព័រដើម › មហារីកប្លោកទឹកនោម › នូវយ៉ាក › New York City
ការសាកល្បងគ្លីនិកសម្រាប់ មហារីកប្លោកទឹកនោម នៅក្នុង New York City, NY
ការសិក្សាចំនួន 35 សម្រាប់ មហារីកប្លោកទឹកនោម កំពុងរកអ្នកចូលរួមនៅតាមទីតាំងក្នុង និងជុំវិញ New York City (ក្នុងចម្ងាយប្រហែល 30 ម៉ាយ)។ បើកការសិក្សាមួយដើម្បីមើលថាតើនរណាអាចចូលរួម និងរបៀបទំនាក់ទំនងទៅកាន់ក្រុមការងារសិក្សា។
អត្ថបទសិក្សាផ្លូវការ (អង់គ្លេស)
កំពុងរកអ្នកចូលរួមសម្រាប់ការសិក្សាមួយនៅទីនេះ? លេចធ្លោនៅផ្នែកខាងលើនៃទំព័រនេះ — $99 សម្រាប់ 30 ថ្ងៃ →
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
កំពុងជ្រើសរើសដំណាក់កាល 2
- Memorial Sloan Kettering Cancer Center, New York
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
កំពុងជ្រើសរើសដំណាក់កាល 3
- Veterans Affairs New York Harbor Healthcare System-Manhattan Campus, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- និង 2 ទៀត
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Memorial Sloan Kettering Cancer Center ( Site 5031), New York
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
កំពុងជ្រើសរើសការសិក្សាសង្កេតស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 2
- Memorial Sloan Kettering Hospital, New York
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
កំពុងជ្រើសរើសដំណាក់កាល 2
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0111), New York
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
កំពុងជ្រើសរើសដំណាក់កាល 2
- NYP/Weill Cornell Medical Center, New York
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
កំពុងជ្រើសរើសដំណាក់កាល 2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Icahn School of Medicine at Mount Sinai, New York
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Columbia University Irving Medical Center, New York
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center 53rd street, New York
- Icahn School of Medicine at Mount Sinai, New York
- និង 3 ទៀត
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
កំពុងជ្រើសរើសដំណាក់កាល 3
- Memorial Sloan Kettering Cancer Center ( Site 0832), New York
A Study of Surgical Techniques During Cystectomy
កំពុងជ្រើសរើសដំណាក់កាល 3
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
កំពុងជ្រើសរើសដំណាក់កាល 3
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical College, New York
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
កំពុងជ្រើសរើសដំណាក់កាល 1
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
កំពុងជ្រើសរើសដំណាក់កាល 2
- Integrated Medical Professionals, PLLC (Solaris), New York
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
កំពុងជ្រើសរើស
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- Laura & Isaac Perlmutter Cancer Center - NYU Langone Health, New York
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
កំពុងជ្រើសរើសដំណាក់កាល 1
- New York University (NYU), New York
- Weill Cornell Medicine, New York
- Icahn School of Medicine at Mount Sinai, New York
- និង 2 ទៀត
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
កំពុងជ្រើសរើសដំណាក់កាល 3
- Memorial Sloan Kettering Cancer Center, New York
A Study of a Side Effects and Resource Navigation Program for People With Cancer
កំពុងជ្រើសរើស
- City College of New York (Data Collection AND Specimen Analysis), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
កំពុងជ្រើសរើសដំណាក់កាល 2/3
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
កំពុងជ្រើសរើសដំណាក់កាល 2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
កំពុងជ្រើសរើសដំណាក់កាល 2
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Icahn School of Medicine at Mount Sinai, New York
- Evelyn H. Lauder Breast and Imaging Centre (BAIC), New York
- និង 2 ទៀត
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
កំពុងជ្រើសរើសដំណាក់កាល 3
- Research Site, New York
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
- Columbia University Irving Medical Center, New York
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
កំពុងជ្រើសរើស
- Integrated Medical Professionals, New York
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
កំពុងជ្រើសរើសដំណាក់កាល 1
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Blue Light Cystoscopy With Cysview® Registry
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- NYU Langone's Perlmutter Cancer Center, New York
Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
កំពុងជ្រើសរើស
- Mount Sinai Hospital, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Massive Bio SYNERGY-AI site, New York
Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)
កំពុងជ្រើសរើសដំណាក់កាល 2
- Columbia University Irving Medical Center/ New York Presbyterian Hospital, New York
ការសាកល្បងសម្រាប់ មហារីកប្លោកទឹកនោម នៅក្នុងទីក្រុងផ្សេងទៀត
- Nashville, TNការសិក្សា 31
- Houston, TXការសិក្សា 31
- Dallas, TXការសិក្សា 27
- Washington, DCការសិក្សា 26
- Boston, MAការសិក្សា 26
- Baltimore, MDការសិក្សា 24
- Los Angeles, CAការសិក្សា 24
- St. Louis, MOការសិក្សា 22
- Seattle, WAការសិក្សា 21
- Chicago, ILការសិក្សា 21
- Philadelphia, PAការសិក្សា 21
- Edison, NJការសិក្សា 21
ការសិក្សាផ្សេងទៀតនៅក្នុង New York City
- មហារីកទ្រូងការសិក្សា 136
- Non-Small Cell Lung Cancerការសិក្សា 121
- មហារីក (គ្រប់ប្រភេទ)ការសិក្សា 109
- មហារីកតូចការសិក្សា 103
- មហារីកដែលរីករាលដាលការសិក្សា 93
- មហារីកពោះវៀនធំ និងទ្វារមាសការសិក្សា 78
- មហារីកស៊ុតការសិក្សា 69
- មហារីកសួតការសិក្សា 60
- ជំងឺ Multiple Myelomaការសិក្សា 60
- មហារីកតំបក់ការសិក្សា 60
- មហារីកស្រទាប់ស្បែកស្តីការសិក្សា 52
- ជំងឺលីកូសេមីមីអេឡូអ៊ីដបន្ទាន់ការសិក្សា 51
ពី ClinicalTrials.gov, ទិន្នន័យទទួលបាននៅថ្ងៃ 6 តុលា 2026។ ការសិក្នានីមួយៗកំណត់លក្ខខណ្ឌលក្ខណៈសម្បត្តិរបស់ខ្លួន; ក្រុមការងារសិក្សាកំណត់ថាតើនរណាអាចចូលរួម។